During the board meeting in September, Staffan Thunell was elected as new chairman of the Neobiomics Board of Directors. We are glad that Staffan Thunell takes on this role in times when Neobiomics is facing some exciting developments. We are also happy that Mårten Österlund, our former chairman, will continue to work as a regular board member.
Staffan Thunell has been part of the Board of Directors since July 2020. He has extensive entrepreneurial experience and expertise from the life-science industry. Over the course of the last 20 years, he has founded several companies in the fields of medical affairs consulting and pharmaceuticals.
If you want to know more about Staffan, you can read the interview we did with him here.